Zebra Capital Management LLC Axogen, Inc. Transaction History

Zebra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $100,177 - $138,911	10,612 New	10,612 $106,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $295,870 - $407,341	-15,993 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $233,817 - $353,925	15,993 New	15,993 $337,000
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $225,468 - $504,632	-13,193 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $136,097 - $223,432	-3,997 Reduced 23.25%	13,193 $486,000
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $170,483 - $247,590	-4,716 Reduced 21.53%	17,190 $864,000
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $307,537 - $507,311	12,604 Added 135.5%	21,906 $800,000
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $172,087 - $266,037	9,302	9,302 $263,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.